October 1, 2024
Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic
Docket Number: FDA-2008-D-0610 Issued by: Guidance Issuing Office Human Foods Program Center for Biologics Evaluation and Research Center for Devices and Radiological Health Center for Drug […]